Author

S. Ochsenreither

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:drug response / drug discovery· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Assay:proteomics· 1

Frequent Co-Authors

W. Weichert· 2 shared A. M. Krackhardt· 1 shared A. Stenzinger· 1 shared B. Haller· 1 shared B. Klink· 1 shared B. Kuster· 1 shared B. Obermayer· 1 shared C. H. Brandts· 1 shared

Activity by Year

2019-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

W. Weichert

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Proteogenomic analysis reveals RNA as an important source for tumor-agnostic neoantigen identification correlating with T-cell infiltration

C. Tretter, N. de Andrade Kraetzig, M. Pecoraro, S. Lange, P. Seifert, C. von Frankenberg, J. Untch, F. S. Dreyer, E. Braeunlein, M. Wilhelm, D. P. Zolg, T. Engleitner, S. Uhrig, M. Boxberg, K. Steiger, , A. M. Krackhardt

This study identifies RNA as a significant source of tumor-agnostic neoantigens, which correlate with T-cell infiltration in multiple cancer types.

bioRxiv · Sep 17, 2022Cancer Biology

Distinct immune evasion in APOBEC-enriched, HPV-negative HNSCC

C. Messerschmidt, B. Obermayer, K. Klinghammer, S. Ochsenreither, D. Treue, A. Stenzinger, H. Glimm, S. Fröhling, T. Kindler, C. H. Brandts, K. Schulze-Osthoff, W. Weichert, I. Tinhofer, F. Klauschen, U. Keilholz, , D. T. Rieke

The paper identifies an APOBEC-enriched subgroup of HPV-negative HNSCC with distinct immunogenic features linked to immune evasion and potential response to immunotherapy.

bioRxiv · Mar 28, 2019Cancer Biology